P21 Rekombinanter Antikörper

P21 Rekombinant Antikörper für WB, IF/ICC, IP, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IF/ICC, IP, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

3N14

Kat-Nr. : 82669-2-PBS

Synonyme

CDKN1A, P21;CDKN1A, 3N14, CDK-interacting protein 1, CIP1



Geprüfte Anwendungen

Produktinformation

82669-2-PBS bindet in WB, IF/ICC, IP, Indirect ELISA P21 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen P21 fusion protein Ag0368
Vollständiger Name cyclin-dependent kinase inhibitor 1A (p21, Cip1)
Berechnetes Molekulargewicht18 kDa
Beobachtetes Molekulargewicht21 kDa
GenBank-ZugangsnummerBC000275
Gene symbol p21
Gene ID (NCBI) 1026
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-A-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

CDKN1A (p21, CIP1, WAF1) is a cyclin-dependent kinase inhibitor. CDKN1A binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at the G1 phase. The expression of CDKN1A is induced by wild-type but not mutant p53 protein, through which CDKN1A mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. CDKN1A can interact with proliferating cell nuclear antigen (PCNA), and plays a regulatory role in S phase DNA replication and DNA damage repair. CDKN1A was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported.